BioMed Research International

BioMed Research International / 2014 / Article

Research Article | Open Access

Volume 2014 |Article ID 632347 |

Lukasz Rabalski, Krzysztof Smietanka, Zenon Minta, Boguslaw Szewczyk, "Detection of Newcastle Disease Virus Minor Genetic Variants by Modified Single-Stranded Conformational Polymorphism Analysis", BioMed Research International, vol. 2014, Article ID 632347, 8 pages, 2014.

Detection of Newcastle Disease Virus Minor Genetic Variants by Modified Single-Stranded Conformational Polymorphism Analysis

Academic Editor: Oscar Perng
Received24 Nov 2013
Accepted12 Mar 2014
Published10 Apr 2014


Newcastle disease and Avian Influenza are considered to be the most dangerous fowl diseases which may cause huge economic losses. Newcastle disease is caused by the enveloped, and single-stranded RNA virus (NDV, APMV-1; belonging to Paramyxoviridae family), which can be further divided into sixteen different genotypes grouped into five pathotypes according to their pathogenicity. It has been reported that low pathogenic virus can greatly increase its pathogenicity even during a single passage. Additionally, due to the widespread use of live vaccines, a mixture of two or more different viruses in one sample can be detected. Hence, there is a great need for establishment of fast, inexpensive, sensitive, and relatively simple diagnostic method for multistrain and quasispecies detection of NDV infection. In this paper we describe a diagnostic method based on RT-PCR followed by a modified version of single-stranded conformational polymorphism analysis using short DNA fragments of gene encoding viral F protein. The method allows for rapid diagnosis of genetic variant emerging from previously stable population which may prevent the spread of the pathogenic viral variant.

1. Introduction

Newcastle disease is an avian viral disease that endemically occurs in Asia, Africa, and Central and South America [1]. The etiological cause of the disease is an enveloped, nonsegmented, negative-sense, and single-stranded RNA virus belonging to Avulavirus genus of Paramyxoviridae family. This genus consists of twelve serotypes of Avian Paramyxoviruses [2]. Newcastle disease virus (NDV) is designated as APMV-1 [3]. It can be further divided into sixteen different genotypes [4, 5].

NDV genome contains 15186, 15192, or 15198 nucleotides depending on genotype and encodes six proteins in the following order: NP (nucleocapsid protein), P (phosphate polymerase cofactor protein), M (membrane associated matrix protein), F (fusion surface glycoprotein), HN (hemagglutinin-neuraminidase surface glycoprotein), and L (large RNA dependent RNA-polymerase) [68]. Paramyxovirus particles usually enter the host organism via the respiratory or gastrointestinal epithelial cells. F protein is activated by HN protein which promotes junctions and fusion of viral and host membranes [9]. Matrix protein dissolves and releases helical nucleocapsid into the cytoplasm of the infected cell [10]. After transcription and translation, newly formed progeny virions bud out of the cell [11].

Newcastle disease is widely spread throughout the globe and is considered to be one of the two most dangerous poultry diseases (second is the avian influenza) that cause huge economic losses in poultry production. The loss of US$161 million by the US Government in 2002 after the outbreak of Newcastle disease in California is one of the most recent cases of the disease.

The name of the disease is derived from the British city “Newcastle-upon-Tyne,” near which it was diagnosed in 1926 for the first time. Almost simultaneously, in the same year, the disease was discovered on Java Island in Indonesia [12]. It was experimentally proven that NDV infects at least 236 avian species [13]. Human infections are rare and usually exhibit as eye conjunctivitis; several infections in pigs have been reported [14, 15]. Naturally selected or laboratory adapted strains of the NDV are thoroughly studied, some of them found application as new oncolytic virotherapeutics that can be used to treat human cancers like melanoma [15, 16].

The main reservoirs of the APMV-1 are waterfowl and migratory birds [17, 18]. During infection with low pathogenic strains often they do not exhibit clinical signs, which allows for the “unnoticed” spread of the virus. The highest mortality (even higher than 90% in 2–6 dpi) among infected birds is observed in domestic fowl (Gallus gallus domesticus) [1]. Virulence of a strain depends mainly on the short amino acid sequence of the precursor protein responsible for fusion of membranes [19]. Highly pathogenic NDV usually contains the following sequence: C-112R/K-R-Q/K/R-R/K-R-F117-N, while low pathogenic has C-112G/E-K/R-Q-G/E-R-L117-N. These motifs are recognized by different cellular proteases which limit the ability for virus propagation only to specific host tissue [20, 21]. World Organisation for Animal Health distinguishes five pathotypes of Newcastle disease virus: viscerotropic and neurotropic velogenic (highest mortality rate, Intracerebral Pathogenicity Index > 1,5), mesogenic (low mortality but moderate signs from respiratory system, ICPI 1,5–0,7), lentogenic (mild respiratory infection with no mortality, life-vaccine strains, ICPI < 0,7), and asymptomatic (no signs or subclinical enteric infections) [22].

Although vaccines based on low pathogenic variants of NDV protect against clinical signs and mortality, they do not prevent infection with highly pathogenic strains, which may be the cause for uncontrolled spread of the virus [23]. This phenomenon may be intensified if chickens are vaccinated at the same time against other viruses (e.g., against infectious bursal disease virus) or if the dose of the vaccine is too small and/or poorly administered [2426].

Molecular diagnostic methods that employ different variations of RT-PCR and real-time PCR techniques allow for sensitive detection and pathotyping of APMV-1 [2737]. All techniques based on endonuclease cleavage or probe/primer hybridization to a specific site are very sensitive to mismatches that often produce false-negative results [37, 38]. Methods that use high resolution or standard melting curve analysis are unable to detect multistrain or quasispecies infection without very expensive, time and resource consuming preanalysis [39]. These deficiencies are the most important after the discovery that highly virulent viruses may arise from progenitor viruses of low virulence, as it was shown during Australian 1998–2002 outbreak [40, 41]. Even a single passage in chicken’s brain can change virus pathotype to velogenic [42, 43].

One of the methods which may help in differentiation as well as in quasi- and multistrain NDV detection is one-step RT-PCR followed by single-stranded conformational polymorphism. Single-stranded conformational polymorphism (SSCP) analysis was first described by Orita et al. [44] who demonstrated that single-stranded DNA fragments with a single base difference can be potentially distinguished on the basis of difference in electrophoretic mobility under native conditions. During the gel run, single-stranded fragments adopt secondary structure depending on the sequence and conditions. Exemplary ssDNA secondary structures are presented in Figure 1. Usually more than one electrophoretic band of ssDNA is observed for a particular DNA fragment due to the fact that often more than one conformer is thermodynamically favorable in experimental conditions. Physicochemical conditions, the most important being ionic strength, pH, and temperature, play an important role in the formation of particular conformers [4547]. In the modification of this technique named multitemperature single-stranded conformational polymorphism (MSSCP), the electrophoretic gel is run at stringently controlled temperatures which are changed stepwise during the run [48]. SSCP analysis has been recently applied to the identification of genetic variation in several groups of viruses [4951]. One of the most useful applications of this technique has been in the identification of quasispecies within the population of viruses making it an effective tool in molecular epidemiology studies [52, 53].

The purpose of this study was to develop a method for inexpensive, quick, and sensitive identification of NDV variants with a point mutation in gene F cleavage site that can lead to increase of the pathogenicity. Ideally, the method should allow for detection of minor quasispecies at relatively low cost in routine diagnostic laboratories.

2. Materials and Methods

2.1. APMV-1 Strains

Full size or fragments of genomes from three reference strains (vaccine La Sota, vaccine Roakin, and Italy) and three Australian strains (isolated during 1998–2002 outbreak in New South Wales) were tested in this study and are listed in Table 1.

StrainTemplates*GenBank acc. numberNucleotide motif**ICPIPathotype

La SotanR, aR, nDAF077761GGGAGACAGGGGCGCCTT 0.4 [1]Lentogenic
RoakinnR, aR, nDAY289000AGGAGACAGAAACGCTTT1.45 [1]Mesogenic
ItalynR, aR, nDAY562989AGGAGGAAGAAACGCTTT1.55 [73]Velogenic
98-1154aR, aDAY935491AGGAGACAGGGGCGTCTT0.47 [60]Lentogenic
99-0868-2aR, aDAY935496AGGAGACAGAGGCGTCTT1.38 [60]Mesogenic
99-0655aR, aDAY935494AGGAGACAGAGGCGTTTT1.61 [60]Velogenic

nR: genomic RNA isolated from live-virus vaccines, aR: RNA obtained by transcription of cloned fusion protein gene fragment from a plasmid, nD: plasmids with cloned cDNA from RT-PCR of genomic RNA, and aD: plasmids with cloned synthetized fusion protein gene fragment.
nucleotide sequence for cleavage site (position 4877–4894 in La Sota genome).
2.2. Template Preparation, RT-PCR Conditions

nR—allantoic fluid from SPF embryonated flock eggs (Lohman, Germany), previously inoculated with La Sota or Roakin NDV strains, was harvested and subjected to RNA extraction using RNeasy Mini Kit according to the manufacturer protocol (Qiagen, USA). RNA from oral and cloacal swabs from chickens infected with La Sota or Roakin NDV strains was purified with the same procedure.

nD—one set of universal (for all Class II APMV-1) degenerate PCR primers for amplification of 123 nt fusion glycoprotein gene fragment was designed. The DNA sequences for this set of primers were as follows: NDV-F (position 4790–4809 in La Sota genome): 5′-GCATACAACAGRACAYTGAC-3′ and NDV-R (position 4893–4912 in La Sota genome): 5′-GCCDATAATGGCRCCTATAA-3′. Synthesis of the first strand and amplification of the DNA were carried out during one-step RT-PCR (AccessQuick RT-PCR System, Promega, USA) procedure. The reaction mixture contained 1 μL template RNA, 12.5 μL AccessQuick Master Mix, 0.5 μL 10 μM NDV-F primer, 0.5 μL 10 μM NDV-R primer, 0.5 μL (2.5 u) AMV Reverse Transcriptase, and 10.5 μL Nuclease-Free Water. The reaction conditions were as follows: 1x [45°C 40 min., 95°C 2 min.], 30x [95°C 30 sec., 43°C 30 sec., 70°C 15 sec.], and 1x [70°C 2 min]. PCR products were electrophoresed in 2% agarose gels using 1x TAE buffer (40 mM TRIS, 20 mM sodium acetate, and 1 mM EDTA adjusted to pH 7.2 with glacial acetic acid) with ethidium bromide and purified (Gel-Out Kit, A&A Biotechnology, Poland) and cloned into the pJet 1.2 vector (CloneJET PCR Cloning Kit, Thermo Scientific, USA) in accordance with the manufacturers protocols. The recombinant plasmids were used to transform the TOP10 strain of E. coli competent cells (Life Technologies, USA). Colonies were isolated and they were grown in liquid medium for purification of recombinant plasmids on silica gel columns (Plasmid Mini, A&A Biotechnology, Poland). After restriction analysis, the recombinant plasmids containing the correct inserts were sent for sequencing to Genomed, Poland. Sequences were aligned using the Geneious R6 PRO software created by Biomatters, available from

aD—three 145 bp DNA oligonucleotides with sequences exactly the same as those in Australian strains of NDV (position 4790–4934 in La Sota genome) presented in Table 1 were synthetized in Genomed, Poland. These fragments were subjected to cloning, restriction analyses, and sequencing as described above.

aR—all purified and checked for correct sequence plasmids were used as template for transcription reaction by TranscriptAid T7 High Yield Transcription Kit (Thermo Scientific, USA) as instructed by the manufacturer. RNA was checked for lack of DNA contamination by RT-PCR as described above without addition of AMV Reverse Transcriptase.

2.3. MSSCP Analyses

Templates nR and aR were subjected to RT-PCR and plasmids (nD and aD) to PCR (no initial 45°C 40 min. step or AMV Reverse Transcriptase). For MSSCP analysis, 3 μL of DNA was added to 10 μL of denaturing buffer (0.1 M NaOH and 10 mM EDTA) and incubated at 98°C for 5 min. The samples were immediately cooled on ice and, prior to loading on the gel, 3 μL of dye solution (0.1% bromophenol blue, 0.1% xylene cyanol in formamide) was added. The mixture was immediately loaded onto 13.5% or 11% native polyacrylamide gel (and with addition of 3% glycerol for 13.5% gel). Electrophoresis was carried out in 0.75x TBE (45 mM Tris, 45 mM boric acid, 1 mM EDTA, and pH 8.0) in DNA Pointer System (BioVectis, Poland) at three or five different temperatures. Before transferring samples onto the gel, a 100Vxh 9°C preelectrophoresis was performed. The MSSCP electrophoresis conditions are shown in Table 2. After electrophoresis, gels were stained using the Silver Stain Kit from BioVectis.

StepVxhTemp. (°C)


3. Results

3.1. Reverse Transcription PCR and Validation of Templates

During the experiments, different types of templates for polymerase amplification reactions were tested (Table 1). For validation of these templates, one-step RT-PCR and PCR were performed. Full genome (nR) or fusion protein fragment (aR, nD, and aD) templates were subjected to amplification with one set of universal degenerate primers (NDF-F and NDF-R). For RT-PCR only RNA (both full genomic and F protein fragment transcribed from a plasmid) and for PCR only DNA (a plasmid with F protein fragment) were used. No differences were observed in the resulting products.

Until now no data have been presented whether the preamplification procedures (like using only small fragment of transcribed RNA instead of full genomic RNA for RT-PCR) affect secondary ssDNA structures and their quantity, which subsequently may alter MSSCP band pattern. To check this, MSSCP analysis for RT-PCR products derived from different templates was conducted. The result is shown in Figure 2 which indicates clearly that there is no differences in ssDNA patterns irrespective of its preparation. This validates the use of synthetic DNA representing NDV strain or genetic variant, instead of viral genome for establishing MSSCP bands pattern.

3.2. Detection and Differentiation of “Shedding” and Quasispecies Infections

To test the ability to detect two different NDV variants in a single sample, a series of mixed template PCRs was prepared. After reaction, MSSCP analysis was performed and ssDNA band patterns were visualized as presented in Figures 3 and 4. The presence of all Australian genetic variants was clearly detected in combinations with each other and with vaccine Roakin strain.

4. Discussion

Low pathogenic strains of NDV in feces of infected birds can remain active for more than two months, and the virus can persist for over two years in bird population [5456]. This has not raised much concern until the last decade of 20th century when it was found that a low pathogenic virus can transform into highly pathogenic with only four point mutations. Such spontaneous change was documented for the first time for Irish velogenic isolates in 1990 [57, 58]. At that time, Australia was considered as a continent free from highly pathogenic strains of APMV-1 [59]. However, ten years later, a similar change in virulence was observed during the outbreak that took place in 1998–2002 in the New South Wales, Australia. Two point mutations in the cleavage site of the F glycoprotein resulted in a complete change of pathotype and threatened poultry farms on the continent. It has been found that the viral population circulating in the environment consisted of a number of intermediate forms, called quasispecies [41, 60]. The idea of constantly changing (mutating) viruses that generate different properties (e.g., virulence) in subpopulations was previously confirmed for many viruses not related to NDV [6163]. This specific feature is most pronounced in RNA viruses because of lack of proofreading properties of RNA polymerase to efficiently repair genomes that undergo replication [64, 65].

The Australian case gave rise to the discussion whether it is possible to detect such events in advance. To cope with the problem we need to establish a method that will meet some basic requirements. This method must be able to detect numerous genetically altered variants in the pool of progenitor viruses as well as it must be able to distinguish between two sequences with only single nucleotide mismatch. Additional advantage of such method should be low cost and simplicity.

The combination of Reverse Transcription real-time, digital PCR with Sanger sequencing or applications of Next Generation Sequencing and oligonucleotide microarrays can give great results, but they are expensive and highly demanding for trained technician and elaborate equipment [39, 66, 67]. As an alternative, many protocols, based on techniques like restriction endonuclease analyses, peptide nucleic acid with gold nanoparticles assay, phage-capturing dot blot, in situ hybridization, RT-PCR, and probe-based real-time RT-PCR, were proposed [6872]. Their main limitation is the need to react with a specific nucleotide sequence responsible for virulence. Single nucleotide mismatches that are responsible for acquiring virulence may not be detected and can lead to false diagnostic results [37, 38].

During our study, we developed a method, based on RT-PCR followed by MSSCP analyses, that meets the requirements described in the second paragraph. In our opinion, fast diagnostics of a new genetic variant that appears in previously stable population could alert veterinary services and lead, after confirmation, to preventive actions for disease eradication. MSSCP can differentiate between lentogenic vaccine, mesogenic vaccine, circulating velogenic, lentogenic natural occurring, and their highly pathogenic mutated NDV variants. This can be achieved by comparison of unknown pattern of silver stained bands to previously established database of known isolates. Even without direct information about pathotype of the unknown sample, it is easy to distinguish potentially unwanted strain of NDV. The technique described above does not require highly sophisticated and expensive tools and is easy to perform by laboratory technical personnel. Additionally it is relatively inexpensive and takes about 5 minutes per sample from the end of one-step RT-PCR until visualization. Main disadvantage (that has no significance for a technician performing the assay) of MSSCP is a lengthy and arduous optimization of gel run conditions like selection of optimum conditions (temperature, voltage, and time) and gel percentage of polyacrylamide and other additives.

5. Conclusions

Many methods have been developed that allow for detecting different pathotypes of Newcastle disease virus. One of the most popular and validated molecular techniques is real-time PCR. The disadvantage of this method is difficulty in detection of multistrain infections and minute changes in sequence that can alter virulence. In this study, we described a method based on a modification of single-stranded conformational polymorphism at specially programmed temperatures (MSSCP) that can be easily applied for NDV screening. We also showed that to prepare a library of MSSCP patterns it is not necessary to use isolated genomic material but only short synthetized nucleotides. In other words, it is possible to create a database of ssDNA band patterns for all-known NDV F gene sequences (e.g., available in NCBI) without need to isolate their genetic material but by synthetizing dsDNA analogs and reverse transcription to RNA. They can be used as a template for RT-PCR and produce exactly the same MSSCP ssDNA band patterns (Figure 2).

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.


This research was cofunded by the National Centre for Research and Development within the Applied Research Programme Grant no. PBS1/B8/2/2012.


  1. D. J. Alexander, R. E. Gough, Y. M. Saif et al., “Newcastle disease, other avian Paramyxoviruses, and Pneumavirus infections,” in Disease of Poultry, vol. 11, pp. 63–92, Iowa State Press, Ames, Iowa, USA, 2003. View at: Google Scholar
  2. C. Terregino, E. W. Aldous, A. Heidari et al., “Antigenic and genetic analyses of isolate APMV/wigeon/Italy/3920-1/2005 indicate that it represents a new avian paramyxovirus (APMV-12),” Archives of Virology, vol. 158, no. 11, pp. 2233–2243. View at: Google Scholar
  3. M. A. Mayo, “A summary of taxonomic changes recently approved by ICTV,” Archives of Virology, vol. 147, no. 8, pp. 1655–1656, 2002. View at: Publisher Site | Google Scholar
  4. S. C. Courtney, L. Susta, D. Gomez et al., “Highly divergent virulent isolates of Newcastle disease virus from the Dominican Republic are members of a new genotype that may have evolved unnoticed for over 2 decades,” Journal of Clinical Microbiology, vol. 52, no. 2, pp. 508–517, 2012. View at: Google Scholar
  5. D. G. Diel, L. H. da Silva, H. Liu, Z. Wang, P. J. Miller, and C. L. Afonso, “Genetic diversity of avian paramyxovirus type 1: proposal for a unified nomenclature and classification system of Newcastle disease virus genotypes,” Infection, Genetics and Evolution, vol. 12, no. 8, pp. 1770–1779, 2012. View at: Publisher Site | Google Scholar
  6. I. Bikel and P. H. Duesberg, “Proteins of Newcastle disease virus and of the viral nucleocapsid,” Journal of Virology, vol. 4, no. 4, pp. 388–393, 1969. View at: Google Scholar
  7. A. Czeglédi, D. Ujvári, E. Somogyi, E. Wehmann, O. Werner, and B. Lomniczi, “Third genome size category of avian paramyxovirus serotype 1 (Newcastle disease virus) and evolutionary implications,” Virus Research, vol. 120, no. 1-2, pp. 36–48, 2006. View at: Publisher Site | Google Scholar
  8. R. A. Lamb and D. Kolakofsky, “Paramyxoviridae: the viruses and their replication,” in Fundamental Virology, pp. 1305–1340, Lippincott-Raven Publishers, Philadelphia, Pa, USA, 2002. View at: Google Scholar
  9. R. K. Plemper, A. L. Hammond, and R. Cattaneo, “Measles virus envelope glycoproteins hetero-oligomerize in the endoplasmic reticulum,” Journal of Biological Chemistry, vol. 276, no. 47, pp. 44239–44246, 2001. View at: Publisher Site | Google Scholar
  10. S. Vidal and D. Kolakofsky, “Modified model for the switch from Sendai virus transcription to replication,” Journal of Virology, vol. 63, no. 5, pp. 1951–1958, 1989. View at: Google Scholar
  11. A. Ali and D. P. Nayak, “Assembly of Sendal virus: M protein interacts with F and HN proteins and with the cytoplasmic tail and transmembrane domain of F protein,” Virology, vol. 276, no. 2, pp. 289–303, 2000. View at: Publisher Site | Google Scholar
  12. D. J. Alexander, “Newcastle disease virus and other avian Paramyxoviruses,” in A Laboratory Manual for the Isolation and Identification of Avian Pathogens, pp. 156–163, American Association of Avian Pathologists, Kennett Square, Pa, USA, 4th edition, 1998. View at: Google Scholar
  13. E. F. Kaleta and C. Baldauf, “Newcastle disease in free-living and pet birds,” in Newcastle Disease, pp. 197–246, Kluwer Academic Publishers, Boston, Mass, USA, 1988. View at: Google Scholar
  14. L. K. Csatary, R. W. Moss, J. Beuth, B. Töröcsik, J. Szeberenyi, and T. Bakacs, “Beneficial treatment of patients with advanced cancer using a Newcastle Disease Virus Vaccine (MTH-68/H),” Anticancer Research, vol. 19, no. 1, pp. 635–638, 1999. View at: Google Scholar
  15. R. Kumar, A. K. Tiwari, U. Chaturvedi et al., “Velogenic newcastle disease virus as an oncolytic virotherapeutics: in vitro characterization,” Applied Biochemistry and Biotechnology, vol. 167, no. 7, pp. 2005–2022, 2005. View at: Google Scholar
  16. J. G. Sinkovics and J. C. Horvath, “Newcastle disease virus (NDV): brief history of its oncolytic strains,” Journal of Clinical Virology, vol. 16, no. 1, pp. 1–15, 2000. View at: Google Scholar
  17. H. Takakuwa, T. Ito, A. Takada, K. Okazaki, and H. Kida, “Potentially virulent Newcastle disease viruses are maintained in migratory waterfowl populations,” Japanese Journal of Veterinary Research, vol. 45, no. 4, pp. 207–215, 1998. View at: Google Scholar
  18. D. Ujvári, E. Wehmann, E. F. Kaleta et al., “Phylogenetic analysis reveals extensive evolution of avian paramyxovirus type 1 strains of pigeons (Columba livia) and suggests multiple species transmission,” Virus Research, vol. 96, no. 1-2, pp. 63–73, 2003. View at: Publisher Site | Google Scholar
  19. R. Rott and H. D. Klenk, “Molecular basis of infectivity and pathogenicity of Newcastle disease virus,” in Newcastle Disease, pp. 197–246, Kluwer Academic Publishers, Boston, Mass, USA, 1988. View at: Google Scholar
  20. M. S. Collins, I. Strong, and D. J. Alexander, “Pathogenicity and phylogenetic evaluation of the variant Newcastle disease viruses termed “pigeon PMV-1 viruses” based on the nucleotide sequence of the fusion protein gene,” Archives of Virology, vol. 141, no. 3-4, pp. 635–647, 1996. View at: Google Scholar
  21. Y. Nagai, H. D. Klenk, and R. Rott, “Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus,” Virology, vol. 72, no. 2, pp. 494–508, 1976. View at: Google Scholar
  22. OIE, Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, vol. 1-2, 7th edition, 2012.
  23. P. J. Miller, C. Estevez, Q. Yu, D. L. Suarez, and D. J. King, “Comparison of viral shedding following vaccination with inactivated and live newcastle disease vaccines formulated with wild-type and recombinant viruses,” Avian Diseases, vol. 53, no. 1, pp. 39–49, 2009. View at: Publisher Site | Google Scholar
  24. K. Nakamura, M. Ito, T. Nakamura et al., “Pathogenesis of Newcastle disease in vaccinated chickens: pathogenicity of isolated virus and vaccine effect on challenge of its virus,” Journal of Veterinary Medical Science, vol. 76, no. 1, pp. 31–36, 2013. View at: Google Scholar
  25. P. J. Miller, C. L. Afonso, J. El Attrache et al., “Effects of Newcastle disease virus vaccine antibodies on the shedding and transmission of challenge viruses,” Developmental and Comparative Immunology, vol. 41, no. 4, pp. 505–513, 2013. View at: Publisher Site | Google Scholar
  26. J. C. F. M. Dortmans, B. P. H. Peeters, and G. Koch, “Newcastle disease virus outbreaks: vaccine mismatch or inadequate application?” Veterinary Microbiology, vol. 160, pp. 17–22, 2012. View at: Publisher Site | Google Scholar
  27. M. G. Wise, D. L. Suarez, B. S. Seal et al., “Development of a real-time reverse-transcription PCR for detection of newcastle disease virus RNA in clinical samples,” Journal of Clinical Microbiology, vol. 42, no. 1, pp. 329–338, 2004. View at: Publisher Site | Google Scholar
  28. C. M. Fuller, M. S. Collins, and D. J. Alexander, “Development of a real-time reverse-transcription PCR for the detection and simultaneous pathotyping of Newcastle disease virus isolates using a novel probe,” Archives of Virology, vol. 154, no. 6, pp. 929–937, 2009. View at: Publisher Site | Google Scholar
  29. D. Nidzworski, L. Rabalski, and B. Gromadzka, “Detection and differentiation of virulent and avirulent strains of Newcastle disease virus by real-time PCR,” Journal of Virological Methods, vol. 173, no. 1, pp. 144–149, 2011. View at: Publisher Site | Google Scholar
  30. S. W. Tan, A. Ideris, A. R. Omar, K. Yusoff, and M. Hair-Bejo, “Detection and differentiation of velogenic and lentogenic Newcastle disease viruses using SYBR Green I real-time PCR with nucleocapsid gene-specific primers,” Journal of Virological Methods, vol. 160, no. 1-2, pp. 149–156, 2009. View at: Publisher Site | Google Scholar
  31. H. M. Pham, S. Konnai, T. Usui et al., “Rapid detection and differentiation of Newcastle disease virus by real-time PCR with melting-curve analysis,” Archives of Virology, vol. 150, no. 12, pp. 2429–2438, 2005. View at: Publisher Site | Google Scholar
  32. A. Yacoub, M. Leijon, M. J. McMenamy et al., “Development of a novel real-time PCR-based strategy for simple and rapid molecular pathotyping of Newcastle disease virus,” Archives of Virology, vol. 157, no. 5, pp. 833–844, 2012. View at: Publisher Site | Google Scholar
  33. T. Farkas, É. Székely, S. Belák, and I. Kiss, “Real-time PCR-based pathotyping of newcastle disease virus by use of TaqMan minor groove binder probes,” Journal of Clinical Microbiology, vol. 47, no. 7, pp. 2114–2123, 2009. View at: Publisher Site | Google Scholar
  34. L. M. Kim, D. L. Suarez, and C. L. Afonso, “Detection of a broad range of class i and II Newcastle disease viruses using a multiplex real-time reverse transcription polymerase chain reaction assay,” Journal of Veterinary Diagnostic Investigation, vol. 20, no. 4, pp. 414–425, 2008. View at: Google Scholar
  35. E. W. Aldous, M. S. Collins, A. McGoldrick, and D. J. Alexander, “Rapid pathotyping of Newcastle disease virus (NDV) using fluorogenic probes in a PCR assay,” Veterinary Microbiology, vol. 80, no. 3, pp. 201–212, 2001. View at: Publisher Site | Google Scholar
  36. L. Zhang, Z. Pan, S. Geng et al., “Sensitive, semi-nested RT-PCR amplification of fusion gene sequences for the rapid detection and differentiation of Newcastle disease virus,” Research in Veterinary Science, vol. 89, no. 2, pp. 282–289, 2010. View at: Publisher Site | Google Scholar
  37. G. Cattoli, C. De Battisti, S. Marciano et al., “False-negative results of a validated real-time PCR protocol for diagnosis of newcastle disease due to genetic variability of the matrix gene,” Journal of Clinical Microbiology, vol. 47, no. 11, pp. 3791–3792, 2009. View at: Publisher Site | Google Scholar
  38. L. M. Kim, C. L. Afonso, and D. L. Suarez, “Effect of probe-site mismatches on detection of virulent Newcastle disease viruses using a fusion-gene real-time reverse transcription polymerase chain reaction test,” Journal of Veterinary Diagnostic Investigation, vol. 18, no. 6, pp. 519–528, 2006. View at: Google Scholar
  39. N. Chen, B. A. Pinsky, B. P. Lee, M. Lin, and I. Schrijver, “Ultrasensitive detection of drug-resistant pandemic 2009 (H1N1) influenza A virus by rare-variant-sensitive high-resolution melting-curve analysis,” Journal of Clinical Microbiology, vol. 49, no. 7, pp. 2602–2609, 2011. View at: Publisher Site | Google Scholar
  40. A. R. Gould, J. A. Kattenbelt, P. Selleck, E. Hansson, A. Della-Porta, and H. A. Westbury, “Virulent Newcastle disease in Australia: molecular epidemiological analysis of viruses isolated prior to and during the outbreaks of 1998-2000,” Virus Research, vol. 77, no. 1, pp. 51–60, 2001. View at: Publisher Site | Google Scholar
  41. J. A. Kattenbelt, M. P. Stevens, P. W. Selleck, and A. R. Gould, “Analysis of Newcastle disease virus quasispecies and factors affecting the emergence of virulent virus,” Archives of Virology, vol. 155, no. 10, pp. 1607–1615, 2010. View at: Publisher Site | Google Scholar
  42. O. S. de Leeuw, L. Hartog, G. Koch, and B. P. H. Peeters, “Effect of fusion protein cleavage site mutations on virulence of Newcastle disease virus: non-virulent cleavage site mutants revert to virulence after one passage in chicken brain,” Journal of General Virology, vol. 84, no. 2, pp. 475–484, 2003. View at: Publisher Site | Google Scholar
  43. Y. Shengqing, N. Kishida, H. Ito et al., “Generation of velogenic Newcastle disease viruses from a nonpathogenic waterfowl isolate by passaging in chickens,” Virology, vol. 301, no. 2, pp. 206–211, 2002. View at: Publisher Site | Google Scholar
  44. M. Orita, H. Iwahana, H. Kanazawa, K. Hayashi, and T. Sekiya, “Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 8, pp. 2766–2770, 1989. View at: Google Scholar
  45. W. E. Highsmith, A. J. Nataraj, Q. Jin et al., “Use of DNA toolbox for the characterization of mutation scanning methods. II: evaluation of single-strand conformation polymorphism analysis,” Electrophoresis, vol. 20, pp. 1195–1203, 1999. View at: Google Scholar
  46. A. J. Nataraj, I. Olivos-Glander, N. Kusukawa, and W. E. Highsmith Jr., “Single-strand conformation polymorphism and heteroduplex analysis for gel-based mutation detection,” Electrophoresis, vol. 20, pp. 1177–1185, 1999. View at: Google Scholar
  47. C. D. O'Connell, D. H. Atha, M. C. Oldenburg et al., “Detection of p53 gene mutation: analysis by single-strand conformation polymorphism and cleavage fragment length polymorphism,” Electrophoresis, vol. 20, pp. 1211–1223, 1999. View at: Google Scholar
  48. R. Kaczanowski, L. Trzeciak, and K. Kucharczyk, “Multitemperature single-strand conformation polymorphism,” Electrophoresis, vol. 22, pp. 3539–3545, 2001. View at: Google Scholar
  49. J. D. Quinto and C. K. Wang, “A high throughput single-stranded conformation polymorphism assay for detection, subtyping and genotyping of influenza viruses,” International Congress Series, vol. 1263, pp. 653–657, 2004. View at: Publisher Site | Google Scholar
  50. V. Y. Lugovtsev, G. M. Vodeiko, C. M. Strupczewski, and R. A. Levandowski, “Simple and rapid strategy for genetic characterization of influenza B virus reassortants,” Journal of Virological Methods, vol. 124, no. 1-2, pp. 203–210, 2005. View at: Publisher Site | Google Scholar
  51. B. Szewczyk, P. Barski, W. Sihler et al., “Detection and identification of baculovirus pesticides by multitemperature single-strand conformational polymorphism,” Journal of Environmental Science and Health, Part B: Pesticides, Food Contaminants, and Agricultural Wastes, vol. 43, no. 7, pp. 539–545, 2008. View at: Publisher Site | Google Scholar
  52. G. Stamenkovic, J. Guduric, Z. Velickovic et al., “Analysis of 5′ non-coding region in hepatitis C virus by single-strand conformation polymorphism and low-stringency single specific primer PCR,” Clinical Chemistry and Laboratory Medicine, vol. 39, no. 10, pp. 948–952, 2001. View at: Publisher Site | Google Scholar
  53. A. M. Roque-Afonso, D. Ducoulombier, G. Di Liberto et al., “Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells,” Journal of Virology, vol. 79, no. 10, pp. 6349–6357, 2005. View at: Publisher Site | Google Scholar
  54. D. R. Kapczynski and D. J. King, “Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak,” Vaccine, vol. 23, no. 26, pp. 3424–3433, 2005. View at: Publisher Site | Google Scholar
  55. J. L. Samuel and P. B. Spradbrow, “Persistence of the V4 strain of Newcastle disease virus in an open-range flock of chickens,” Veterinary Record, vol. 124, no. 8, pp. 193–196, 1989. View at: Google Scholar
  56. M. Frölich, S. Cortez de Jäckel, and T. Selhorst, “The tenacity of Newcastle disease virus (LaSota) in the excrement of laying hens in different housing systems,” Deutsche Tierarztliche Wochenschrift, vol. 99, no. 12, pp. 494–499, 1992. View at: Google Scholar
  57. M. S. Collins, J. B. Bashiruddin, and D. J. Alexander, “Deduced amino acid sequences at the fusion protein cleavage site of Newcastle disease viruses showing variation in antigenicity and pathogenicity,” Archives of Virology, vol. 128, no. 3-4, pp. 363–370, 1993. View at: Publisher Site | Google Scholar
  58. M. S. Collins, S. Franklin, I. Strong, G. Meulemans, and D. J. Alexander, “Antigenic and phylogenetic studies on a variant Newcastle disease virus using anti-fusion protein monoclonal antibodies and partial sequencing of the fusion protein gene,” Avian Pathology, vol. 27, no. 1, pp. 90–96, 1998. View at: Google Scholar
  59. P. B. Spradbrow, M. MacKenzie, and S. E. Grimes, “Recent isolates of Newcastle disease virus in Australia,” Veterinary Microbiology, vol. 46, no. 1–3, pp. 21–28, 1995. View at: Publisher Site | Google Scholar
  60. J. A. Kattenbelt, M. P. Stevens, and A. R. Gould, “Sequence variation in the Newcastle disease virus genome,” Virus Research, vol. 116, no. 1-2, pp. 168–184, 2006. View at: Publisher Site | Google Scholar
  61. E. L. Delwart and C. J. Gordon, “Tracking changes in HIV-1 envelope quasispecies using DNA heteroduplex analysis,” Methods, vol. 12, no. 4, pp. 348–354, 1997. View at: Publisher Site | Google Scholar
  62. G. Sánchez, A. Bosch, G. Gómez-Mariano, E. Domingo, and R. M. Pintó, “Evidence for quasispecies distributions in the human hepatitis A virus genome,” Virology, vol. 315, no. 1, pp. 34–42, 2003. View at: Publisher Site | Google Scholar
  63. M. Figlerowicz, P. Jackowiak, P. Formanowicz et al., “Hepatitis C virus quasispecies in chronically infected children subjected to interferon-ribavirin therapy,” Archives of Virology, vol. 155, no. 12, pp. 1977–1987, 2010. View at: Publisher Site | Google Scholar
  64. E. Domingo, C. Escarmis, N. Sevilla et al., “Basic concepts in RNA virus evolution,” The Journal of the Federation of American Societies for Experimental Biology, vol. 10, pp. 859–864, 1996. View at: Google Scholar
  65. A. S. Lauring, J. Frydman, and R. Andino, “The role of mutational robustness in RNA virus evolution,” Nature Reviews: Microbiology, vol. 11, no. 5, pp. 327–336, 2013. View at: Publisher Site | Google Scholar
  66. C. de Battisti, A. Salomoni, S. Ormelli, I. Monne, I. Capua, and G. Cattoli, “Rapid pathotyping of Newcastle Disease Virus by pyrosequencing,” Journal of Virological Methods, vol. 188, no. 1-2, pp. 13–20, 2013. View at: Publisher Site | Google Scholar
  67. O. Lung, A. Beeston, S. Ohen-Adjei et al., “Electronic microarray assays for avian influenza and Newcastle disease virus,” Journal of Virological Methods, vol. 185, no. 2, pp. 244–253, 2012. View at: Publisher Site | Google Scholar
  68. M. Mase and K. Kenehira, “Simple differentiation of avirulent and virulent strains of avian paramyxovirus serotype-1 (Newcastle disease virus) by PCR and restriction endonuclease analysis in Japan,” Journal of Veterinary Medical Science, vol. 74, no. 12, pp. 1661–1664, 2012. View at: Publisher Site | Google Scholar
  69. V. G. Joshi, K. Chindera, A. K. Singh et al., “Rapid label-free visual assay for the detection and quantification of viral RNA using peptide nucleic acid (PNA) and gold nanoparticles (AuNPs),” Analytica Chimica Acta, vol. 759, pp. 1–7, 2013. View at: Publisher Site | Google Scholar
  70. I. Oldoni, C. C. Brown, D. J. King, S. Samal, and B. S. Seal, “The use of in situ hybridization and immunohistochemistry to study the pathogenesis of various Newcastle disease virus strains and recombinants in embryonated chicken eggs,” Microbial Pathogenesis, vol. 39, no. 3, pp. 69–75, 2005. View at: Publisher Site | Google Scholar
  71. A. K. Tiwari, R. S. Kataria, T. Nanthakumar, B. B. Dash, and G. Desai, “Differential detection of Newcastle disease virus strains by degenerate primers based RT-PCR,” Comparative Immunology, Microbiology and Infectious Diseases, vol. 27, no. 3, pp. 163–169, 2004. View at: Publisher Site | Google Scholar
  72. T. C. Lee, K. Yusoff, S. Nathan, and W. S. Tan, “Detection of virulent Newcastle disease virus using a phage-capturing dot blot assay,” Journal of Virological Methods, vol. 136, no. 1-2, pp. 224–229, 2006. View at: Publisher Site | Google Scholar
  73. A. Daniel, Charakterystyka krajowych szczepów wirusa rzekomego pomoru drobiu z uwzględnieniem zastosowania przeciwciał monoklonalnych [Ph.D. thesis], PIWet-PIB, Pulawy, Poland, 2004.

Copyright © 2014 Lukasz Rabalski et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Related articles

No related content is available yet for this article.
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

No related content is available yet for this article.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.